Contemporary viewpoint at vegetative dystonia syndrome
DOI: https://dx.doi.org/10.18565/therapy.2018.7-8.57-62
G.M. Dyukova
Department of nervous diseases of FSAEI of HE «I.M. Sechenov First State Medical University» of the Ministry of Healthcare of Russia (Sechenov University)
Such a diffused condition as vegetative dystonia syndrome (SVD) is one of the most frequent diagnoses in Russian neurological practice. Last years, not only significant terminological and classification changes relating to SVD have occurred in the world, but the principles of making this diagnosis have changed: the «positive diagnosis» has replaced the «diagnosis of exclusion». «Positive diagnosis» is based on 4 criteria – stressing somatic symptoms, emotional affective component, inadequate thoughts, behavior changes. Combined therapy of SVD should be aimed not only at the relief of the leading symptom / syndrome and the influence at cognitive, emotional, behavioral disorders, but also at the prevention of recurrence and further progression of the disease.
Keywords: vegetative dystonia syndrome, anxiolytics, antidepressants, psychotherapy
Literature
Международная классификация болезней (10-й пересмотр). Классификация психических и поведенческих pасстpойств. (Клинические описания и указания по диагностике). ВОЗ. Пеp. с англ. Под pед. Ю.Л. Hуллеpа, С.Ю. Циpкина. Россия, СПб., 1994. Sharpe M., Mayou R., Bass C. Concepts, theories and terminology. In: R. Mayou, C. Bass, M. Sharpe, eds. Treatment of functional somatic symptoms. Oxford: Oxford University Press. 1995: 3–16. ABC of Medically Unexplained Symptoms. January Ed. C. Burton. BMJ. Books. 2013. ISBN: 978-1-119-96725-5. Perkin G.D. An analysis of 7836 successive new outpatient referrals. J. Neurol. Neurosurg. Psychiatr. 1989; 52: 447–8. Hallett M. Psychogenic Movement Disorders: Cris. Neurol. Curr. Neurol. Neurosci. Rep. 2006; 6: 269–71. DSM-V. Diagnostic and Statistical Mannual of mental disorders. Washington, 1980–1994–2013. WHO (2015b). International Classification of Diseases, 11th edition, beta draft, Bodily distress disorder. Available online at http://id.who.int/icd/entity/767044268 (accessed 19 September 2015). Fishbain D.A., Cutler R.B., Rosomoff H.L., Rosomoff R.S. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med. 1998; 60(4): 503–9. Freire R.C., Hallak J.E., Crippa J.A., Nardi A.E. New treatment options for panic disorder: clinical trials from 2000 to 2010. Exp. Opin. Pharmacother. 2011; 12(9): 1419–28. Gorman J.M. The use of newer antidepressants for panic disorder. J. Clin. Psychiatry. 1997; 58(Suppl. 14): 54–8; discussion 59. Pae C.U., Marks D.M., Patkar A.A., Masand P.S., Luyten P., Serretti A. Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants. Exp. Opin. Pharmacother. 2009; 10(10): 1561–70. Leombruni P., Piero A., Lavagnino L., Brustolin A., Campisi S., Fassino S. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with binge eating disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008; 32(6): 1599–605. Staab J.P., Ruckenstein M.J., Amsterdam J.D. A prospective trial of sertraline for chronic subjective dizziness. Laryngoscope. 2004; 114(9): 1637–41. Bandelow B., Boerner R.J., Kasper S., Linden M.,Wittchen H.U., Möller H.J. The diagnosis and treatment of generalized anxiety disorder. Dtsch. Arztebl. Int. 2013; 110(17): 300–10. Doi: 10.3238/arztebl.2013.0300.
About the Autors
Galina M. Dyukova, MD, professor of the Department of nervous diseases of the Institute of Professional education of FSAEI of HE «I.M. Sechenov First State Medical University» of the Ministry of Healthcare of Russia (Sechenov University) Address: 111123, Moscow, 86 Shosse Enthuziastov St., GBUZ Moscow Clinical Research Center of DZM. Tel.: +79687306364. E-mail: nervkafedra@gmail.com
Русский
